Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA-ER in GNE-related Thrombocytopenia
NCT02845609Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of aceneuramic acid in Thrombocytopenia, sponsored by Hadassah Medical Organization. Started Sep 2016; status: completed.
02
Drugs
aceneuramic acid
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02845609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845609.